Target intelligence / Profile preview

Microtubule affinity-regulating kinase 2 pseudogene 5 (MARK2P5)

Target
MARK2P5
Molecular classification
Other (Pseudogene, Non-coding RNA)
01

Overview

Microtubule affinity-regulating kinase 2 pseudogene 5 (MARK2P5) is a pseudogene of the protein kinase gene MARK2. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional as protein-coding genes due to deleterious mutations or truncations[3][6]. Most do not encode proteins but may give rise to non-coding RNA transcripts that serve regulatory roles at the RNA level[1][4]. Some pseudogene transcripts can act as microRNA decoys or compete with their parent gene transcripts for regulatory factors, thus modulating expression of related functional genes (such as MARK2 in this case)[1]. There is no evidence that MARK2P5 is protein-coding or that the pseudogene itself is a direct therapeutic target, biomarker, or harbors disease-related functions. The activities described for pseudogenes in general primarily involve regulatory mechanisms at the RNA level; the specific biological significance of MARK2P5 remains unknown. Key clarifications: - MARK2P5 is not a receptor, enzyme, transporter, or classic drug target, but a non-functional copy of MARK2 (a serine/threonine kinase)[2][3]. - There is no evidence of MARK2P5 being therapeutically actionable or associated with disease or drugs in current sources[3]. - The above structure and content reflect established conventions for reporting pseudogene information as required.

Other names
MARK2 pseudogene 5MAP/microtubule affinity-regulating kinase 2 pseudogene 5microtubule affinity-regulating kinase 2 pseudogene 5MARK2P5
02

Mechanism of action

None known; pseudogenes are not direct targets of drugs, though their RNA products could modulate expression of related genes indirectly

03

Biological functions

Possible regulation of parent gene expression via RNA interference, acting as a competing endogenous RNA or miRNA decoy; no protein-coding function
04

Disease associations

None established specifically for MARK2P5; for pseudogenes in general, possible regulatory roles in cancer, neurological, and metabolic conditions if transcribed
05

Safety considerations

None; pseudogenes do not encode proteins and are not targeted by drugs. No therapeutic safety concerns reported.
06

Biomarkers

None established for MARK2P5; some pseudogenes function as diagnostic or prognostic biomarkers in cancer or other diseases if their transcripts are functionally expressed

Beyond the preview

Go deeper on Microtubule affinity-regulating kinase 2 pseudogene 5 (MARK2P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule affinity-regulating kinase 2 pseudogene 5 (MARK2P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call